The Italian Pharmaceutical Industry
Italy’s pharma industry is rewriting Europe’s healthcare story — with soaring exports, €1.6B in R&D, and bold innovation driving growth. Discover how this powerhouse is shaping the future of medicine and setting global benchmarks in pharmaceutical excellence.
The Italian pharmaceutical industry is technologically advanced, with a strong leadership position in Europe and beyond. A sector that has seen strong growth in the past years and is capable of standing out for its high investment in research and development.
The 290 industry players, the main Italian and multinational pharmaceutical and biomedical companies, can boast production of over 37 billion euros, with more than 66,500 people that contribute to these results, rising to 146,000 if indirect employees are considered, a number that has increased rapidly in five years thanks to the sector’s dynamism and investment policies.
More than 70% of the workforce is employed in companies with more than 250 employees. Another element testifying to the vitality of the pharmaceutical sector is research and development expenditure, which stands at EUR 1.6 billion.
Added to this is a marked vocation for exports, with an increase of 58% over the past three years, growth has risen to 168% if we look at the last ten years, making Italy and Germany the leading nation in Europe in this field.The companies are located mainly in Lombardia, Lazio, Veneto and Toscana.
The expenditure of the Italian national health service is 126.6 billion euros, of…
Create an account to continue reading
Create AccountAlready have an account? Sign in
Need an expert in this space?
Talk to an Industry Expert
Knowledge Ridge connects decision-makers with carefully vetted subject matter experts for one-on-one calls, research sprints, and advisory engagements — across 11 sectors and 163 sub-industries globally.
Comments
No comments yet. Be the first to comment!